NCT02559479

Brief Summary

The objective of the study is to assess the effect of low-calorie diets with normal (18%) vs. high (35%) protein (mainly coming from animal source) composition on body weight and carbohydrates metabolism in overweight and obese subjects with pre-diabetes or diabetes. A dietary intervention is carried out during 6 months in 100 subjects who are individually randomized to an energy-restricted diet with two types of macronutrients composition: 1) 35% protein, 30% fat and 35% carbohydrates and 2) 18% protein, 30% fat and 52% carbohydrates. Around 80% of total protein in diet comes from animal source (of whom around 40% from lean red meat). Subjects are provided with weekly menus and different recipes to use them as part of the diet. Monitoring visits with the nutritionist will be performed every 15 days. At the beginning of the study, after 3 and 6 months, the following parameters are determined: anthropometric (weight, waist circumference, body mass index and body composition), blood pressure, dietary (72-hours dietary registry) and exercise and biochemical analysis (total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, apolipoproteins A1 and B, iron, transferring, ferritin, uric acid, glucose, HbA1c, insulin, adiponectin and resistin). Urine samples are also collected to assess microalbuminuria and ureic nitrogen.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

September 22, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 24, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

December 2, 2016

Status Verified

December 1, 2016

Enrollment Period

1.8 years

First QC Date

September 22, 2015

Last Update Submit

December 1, 2016

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in glucose.

    After 3 and 6 months of intervention.

  • Change in glycated hemoglobin.

    After 3 and 6 months of intervention.

  • Change in insulin resistance (HOMA index).

    After 3 and 6 months of intervention.

Secondary Outcomes (4)

  • Change in body weight.

    After 3 and 6 months of intervention.

  • Change in body composition.

    After 3 and 6 months of intervention.

  • Change in waist circumference.

    After 3 and 6 months of intervention.

  • Change in lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, non HDL cholesterol, triglycerides and apolipoproteins).

    After 3 and 6 months of intervention.

Study Arms (2)

18%-Protein diet

ACTIVE COMPARATOR

Energy-restricted diet wit the following composition: 18% protein, 30% fat and 52% carbohydrates

Behavioral: Weight loss interventional study with a low-calorie 18%-protein diet

35%-Protein diet

ACTIVE COMPARATOR

Energy-restricted diet wit the following composition: 35% protein, 30% fat and 35% carbohydrates

Behavioral: Weight loss interventional study with a low-calorie 35%-protein diet

Interventions

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18-70 years old.
  • Body mass index between 27.5 - 40.
  • Steady weight (± 4 kg) in the last 2 months.
  • Glycated hemoglobin between 6 - 7%.

You may not qualify if:

  • Anti-diabetic drugs (oral or subcutaneous) in the last 2 months.
  • Lipid-lowering drugs in the last 2 months.
  • Gouty arthritis in the last 2 years or uric acid \> 735 mg/dl.
  • Presence of uncontrolled endocrinological pathology (including hypothyroidism).
  • Hepatic chronic disease (glomerular filtration rate \< 45 ml/min).
  • Renal, inflammatory or tumoral diseases.
  • Drugs which could interfere in glucose or lipid metabolism such as androgens, corticosteroids (except for those with topic administration) and estrogen replacement therapy.
  • Intake of functional foods with plant sterols in the past 6 weeks.
  • High alcohol intake (\> 30 g per day).
  • Any serious disease which involves less than 1 year life expectancy or, in investigators judgment, limit the follow-up of an homogeneous diet throughout the study.
  • Pregnancy or intention of pregnancy during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fernando Civeira

Zaragoza, Zaragoza, 50009, Spain

RECRUITING

Related Publications (1)

  • Marco-Benedi V, Perez-Calahorra S, Bea AM, Lamiquiz-Moneo I, Baila-Rueda L, Cenarro A, Civeira F, Mateo-Gallego R. High-protein energy-restricted diets induce greater improvement in glucose homeostasis but not in adipokines comparing to standard-protein diets in early-onset diabetic adults with overweight or obesity. Clin Nutr. 2020 May;39(5):1354-1363. doi: 10.1016/j.clnu.2019.06.005. Epub 2019 Jun 15.

MeSH Terms

Conditions

Weight LossObesityDiabetes Mellitus

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Study Officials

  • Fernando Civeira, MD, PhD

    Unidad Clínica y de Investigación en Lípidos y Arteriosclerosis; Hospital U. Miguel Servet; IIS Aragón

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fernando Civeira, MD, PhD

CONTACT

Rocio Mateo-Gallego, RD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 22, 2015

First Posted

September 24, 2015

Study Start

September 1, 2015

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

December 2, 2016

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will share

Locations